AI Article Synopsis
- - Statins are effective for cholesterol control but can lead to a rare and serious condition called statin-induced necrotizing autoimmune myopathy (SINAM).
- - The report discusses SINAM's epidemiology, symptoms, diagnostic challenges, and evolving theories about its causes and treatments.
- - Emphasizing the importance of early diagnosis and a multidisciplinary approach, the article also calls for more research to improve understanding and management of SINAM.
Article Abstract
Statins are widely prescribed to patients for their efficiency in cholesterol management. However, they carry the risk of inducing a relatively rare, serious, and potentially life-threatening condition known as statin-induced necrotizing autoimmune myopathy (SINAM). This case report provides an in-depth analysis of SINAM, focusing on its epidemiology, clinical presentation, and the challenges involved in accurate diagnosis. In addition, we review evolving theories addressing its pathogenesis and current therapeutic approaches. This report identifies the need for early diagnosis and intervention and recommends a multidisciplinary approach to optimize patient outcomes. This article also highlights the need for further research studies to enhance our understanding of SINAM and its management.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11490311 | PMC |
| http://dx.doi.org/10.7759/cureus.69751 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!